|
 |
|
|
|
 |
|
|
|
Europe Strives for a More Efficient Generic-Drug Approval Framework
Proposals to make the decentralized procedure more efficient were discussed at the January 2015 EGA conference.

|
|
USP Publishes Monoclonal Antibody Guidelines
A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
 |
|
|
|
Considering GMPs In Room Design
Cleanability is crucial when choosing components for GMP manufacturing areas.
 |
|
 |
|
Novartis and Juno Settle Over CAR-T Therapy Technology
Novartis will make payments to Juno to settle a patent dispute covering chimeric antigen receptor T-cell (CAR-T) therapies.
 |
|
NIH Announces Positive Results for Experimental Ebola Vaccine
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
 |
|
How to Streamline your Quality & Compliance Processes with Risk Assessment
In this white paper, learn about the best practices to using Risk Assessment in a QMS, how to identify critical events, mitigate the risk, and prevent re-occurrence of these events, and how building a risk matrix will facilitate the decision making process.
Download White Paper Now
|
|
 |
|
SAFC Introduces New Media System
The system is compatible with a wide range of industrial CHO cell lines.
 |
|
Theravectys Given Green Light to Produce Lentiviral Vectors for Clinical Use and CAR-T Cell Therapies
Theravectys has been granted authorization by the French National Agency for Medicines and Health Product Safety to produce lentiviral vectors for Phase I to Phase III testing at its manufacturing plant.

|
|
A world-leading tablet compression solutions provider, Natoli Engineering Company uses the highest quality materials to create efficient, durable and highly performing tablet compression tooling. We manufacture all punch configurations including single-tip, multiple-tip, micro tab, exotic shapes, IMA Comprima, die table segments and more, from a variety of high-quality steel types and specialty coatings. Request a quote and view informative content on our website. Click here
|
|
Onyx Scientific to Expand GMP Capability
The move was made to meet an upsurge in Phase I/II GMP campaigns from clients in Europe and the United States.
 |
|
ISPE Announces 2015 Facility of the Year Category Winners
Facilities in China, Ireland, Germany, and the United States have been recognized by ISPE in the 2015 Facility of the Year Awards program.
 |
|
Practical Guidance for Successful Maammalian Cell Banking and Cell Line Characterization Live Webinar: Thursday, May 14, 2015 at 8 am PDT/ 11 am EDT/ 4 pm BST/ 5 pm CEST Join us for this informative webinar, presented by the team at Eurofins Lancaster Laboratories, to
learn about the various aspects of cell banking and cell line characterization, including GMP production master and working cell banks, GMP non-production (e.g. bioassay) master and working cell banks, R&D cell banks or banking for end of production cells. |
|
GSK Announces US Vaccine R&D Center
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
 |
|
Catalent Acquires Australia's Pharmapak Technologies
Catalent acquires Pharmapak Technologies, a pharmaceutical packaging company based in New South Wales, Australia.

|
|

©2015, UBM Advanstar
485F US Highway 1 South, Suite 210
Iselin, NJ 08830
|
|
|
|
 |
Advertisement:
Pharmaceutical Technology Solid Dosage Combo
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development.
... Click here |
Contact Us
Click here to contact editorial.
Click here to contact sales.
|